Skip to content

Comparison of the effectiveness of platelet-rich plasma (PRP), ozone, and corticosteroids in reducing pain in patients with post-ankle bursitis.

Comparison of the effectiveness of PRP, ozone and corticosteroids in reducing pain in patients with post-anthesis bursitis.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241211064021N3
Enrollment
60
Registered
2025-03-13
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of the effectiveness of PRP, ozone and corticosteroids in reducing pain in patients with post-anthesis bursitis. Soft tissue disorders related to use, overuse and pressure

Interventions

Intervention 1: Intervention group1: Patients in the LCI group: 40 mg of prednisolone and one milliliter of 1% lidocaine are injected under ultrasound guidance. Intervention 2: Intervention group2: Pa

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Diagnosis of post-anthesis bursitis based on clinical features and imaging by a specialist physician Duration of infection at least 3 months

Exclusion criteria

Exclusion criteria: Having other knee diseases at the same time, such as advanced osteoarthritis Having systemic diseases such as rheumatoid arthritis

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: Determination and comparison of the amount and severity of pain is measured at regular intervals such as before treatment, 1 month, 3 months, and 6 months after treatment. Method of measurement: Using standard pain scales such as the Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS), the patient rates the intensity of their pain from 0 (no pain) to 10 (the most severe pain possible).

Secondary

MeasureTime frame
Improve performance. Timepoint: Similar to the main outcome variable (before treatment, 1 month, 3 months and 6 months after treatment). Method of measurement: Using performance assessment questionnaires such as the WOMAC Knee Performance Questionnaire and the Activities of Daily Living (ADL) Questionnaire, which assesses the patient's ability to perform daily activities such as walking, climbing stairs, etc.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Saleh Nia

Hamedan University of Medical Sciences

Farhad_salehnia@yahoo.com+98 81 3131 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026